These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7002067)

  • 1. Reduced prostacyclin activity in systemic lupus erythematosus.
    McVerry BA; Machin SJ; Parry H; Goldstone AH
    Ann Rheum Dis; 1980 Oct; 39(5):524-5. PubMed ID: 7002067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lupus anticoagulant--its role and significance in the pathogenesis of thrombosis].
    Styczyńska M; Chojnowski K; Matusewicz W; Krykowski E
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):151-3. PubMed ID: 1437805
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations.
    Kant KS; Dosekun AK; Chandran KG; Glas-Greenwalt P; Weiss MA; Pollak VE
    Thromb Res; 1982 Sep; 27(6):651-8. PubMed ID: 6758185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
    Carreras LO; Vermylen JG
    Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophlebitis in systemic lupus erythematosus.
    Peck B; Hoffman GS; Franck WA
    JAMA; 1978 Oct; 240(16):1728-30. PubMed ID: 691169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin in systemic lupus and anticardiolipin syndrome.
    Asherson RA; Harris EN; Hughes GR; Ritter JM; Barrow SE; Jones M
    Ann Rheum Dis; 1987 May; 46(5):422-3. PubMed ID: 3296970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Levels of thromboxane and prostacyclin in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Alekberova ZS; Reshetniak TM; Nasonov EL; Kalashnikova LA; Aleksandrova EN; Mach ZS; Rud'ko IA; Sushkevich GN; Kubatiev AA
    Klin Med (Mosk); 1994; 72(6):31-5. PubMed ID: 7898004
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.
    Rustin MH; Bull HA; Machin SJ; Isenberg DA; Snaith ML; Dowd PM
    J Invest Dermatol; 1988 May; 90(5):744-8. PubMed ID: 3129519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.
    Jarrett MP; Green D; Ts'ao CH
    J Clin Pathol; 1983 Mar; 36(3):357-60. PubMed ID: 6826782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased plasminogen activator but normal prostacyclin activity in rat veins during development of experimental thrombosis.
    Mysliwiec M; Villa S; Kornblihtt L; de Gaetano G; Donati MB
    Thromb Res; 1980 Apr 1-15; 18(1-2):159-65. PubMed ID: 6996209
    [No Abstract]   [Full Text] [Related]  

  • 13. "Lupus" and prostacyclin formation.
    Slater D
    Lancet; 1981 Feb; 1(8216):393. PubMed ID: 6110032
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
    Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
    Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of prostacyclin production from vascular endothelial cells by plasma, serum and platelets under normal and pathological conditions.
    Seid JM; Jones PB; Hughes P; Russell RG
    Agents Actions Suppl; 1982; 11():83-92. PubMed ID: 6758553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Lupus" anticoagulant and prostacyclin.
    Carreras LO; Vermylen J
    Lancet; 1981 Mar; 1(8221):665. PubMed ID: 6110887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.